BioCentury features ImmunGene’s interferon payload technology and malignancy antibodies ImmunGene, Inc here ., a kept drug development company centered on targeted antibody therapeutics privately, announced today a profile of the business and its own interferon payload technology system and medication discovery pipeline is presented in the February 7 problem of BioCentury, probably the most widely examine publications in the pharma and biotech sectors. ( The publication noted that, ImmunGene’s CEO Sanjay Khare ‘anticipates licensing deals is a key component of ImmunGene’s technique. ‘We visit a potential model where we out-permit our cytokine payload technology and in-permit antibodies or antibody targets that may deliver the payload to take care of cancer as well as perhaps other illnesses,’ he stated.’ Dr.

hair loss treatment

.. BioForce Nanosciences pursues support for ViriChip platform BioForce Nanosciences continues their work to fund advancement of the ViriChip system, a patented system made to and nondestructively detect and identify whole infections rapidly. Produced by BioForce and permitted by BioForce’s Nano eNabler molecular printer, the ViriChip system can have a significant effect in biodefense by creating ultraminiaturized biodetection gadgets. BioForce Nanosciences offers three main product focus areas: 1) instrumentation, 2) consumables, and 3) applications. The ViriChip platform is merely one program that BioForce’s R&D department is rolling out using the Nano eNabler program. The ViriChip technology is normally sensitive and specific more than enough to detect a number of different pathogens predicated on the availability of catch reagents.